Camlin Fine Sciences Limited — Board Meeting, 22-11-2024: Outcome of Board Meeting

The Board of Directors of Camlin Fine Sciences has announced a board meeting outcome where it approved a revised Rights Issue amounting to a maximum of ₹225 crores. Additionally, the board authorized the raising of funds through the issuance of up to 10,000 non-convertible debentures valued at ₹100 crores on a private placement basis. The NCDs will have a 16% per annum interest rate, payable quarterly, with specific terms for additional coupons. These decisions signal a proactive approach to bolster the company's financial strategy and liquidity.